HMOX1 and adult T-cell leukemia/lymphoma: The data is in the support of a study about the role of HO-1 in Adult T-cell Leukemia (ATL), which states that HO-1 increases the anticancer effects of bortezomib (a proteasome inhibitor) in ATL cells.